Controlled Drugs and Substances Act

Canada
This article is part of a series on the politics and government of Canada
Government
The Crown Monarch (Elizabeth II) Governor General (His Excellency Rt. Hon. David Lloyd Johnston) Monarchy in the Provinces of Canada Lieutenants-Governor Royal Prerogative
Executive (Queen-in-Council) Queen's Privy Council Prime minister (Justin Trudeau) Cabinet (29th ministry) Ministries President of the Privy Council Clerk of the Privy Council Privy Council Office Civil Service Provincial and territorial executive councils Premiers
Legislative (Queen-in-Parliament) Federal parliament Senate Speaker of the Senate Government Leader in the Senate Opposition Leader in the Senate Senate divisions House of Commons Speaker of the house Government Leader in the house Opposition Leader in the house Her Majesty's Loyal Opposition Leader of the Opposition Shadow cabinet Provincial and territorial parliaments
Judicial (Queen-on-the-Bench) Court system Supreme court Federal chief justice (Beverley McLachlin) Provincial and territorial courts Provincial chief justices Constitution British North America Acts Peace, order, and good government Charter of Rights and Freedoms
Elections Federal electoral districts Federal electoral system 42nd federal election (2015) Provincial electoral districts Politics of the provinces
Local government Municipal government
Related topics Federalism Structure of the federal government Constitutional law Regions Political culture Foreign relations Office-holders Political movements Aboriginal self-government First Nations bands
Other countries Atlas

The Controlled Drugs and Substances Act is Canada's federal drug control statute. Passed in 1996 under Prime Minister Jean Chrétien's government, it repeals the Narcotic Control Act and Parts III and IV of the Food and Drug Act and establishes eight Schedules of controlled substances and two Classes of precursors. It provides that "The Governor in Council may, by order, amend any of Schedules I to VIII by adding to them or deleting from them any item or portion of an item, where the Governor in Council deems the amendment to be necessary in the public interest."

The Act serves as the implementing legislation for the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

List of drugs

The list below reflects the list of drugs scheduled in Canada's Controlled Drugs and Substances Act.

On March 12, 2012, controversial Bill C-10, the Safe Streets and Communities Act was passed into law. Amphetamines and their isomers, derivatives, and analogues, including MDA and MDMA, as well as potential "date rape drugs" flunitrazepam and GHB were rescheduled from Schedule III to Schedule l. Dealers of Schedule I drugs now face mandatory minimum sentencing of 1 year imprisonment. Also, the rescheduling imposes harsher punishment for possession. For example; "Possession of substance

4 (1) Except as authorized under the regulations, no person shall possess a substance included in Schedule I, II or III.

Marginal note:Obtaining substance

(2) No person shall seek or obtain

(a) a substance included in Schedule I, II, III or IV, or

(b) an authorization to obtain a substance included in Schedule I, II, III or IV

from a practitioner, unless the person discloses to the practitioner particulars relating to the acquisition by the person of every substance in those Schedules, and of every authorization to obtain such substances, from any other practitioner within the preceding thirty days.

Marginal note:Punishment

(3) Every person who contravenes subsection (1) where the subject-matter of the offence is a substance included in Schedule I

(a) is guilty of an indictable offence and liable to imprisonment for a term not exceeding seven years; or

(b) is guilty of an offence punishable on summary conviction and liable

(i) for a first offence, to a fine not exceeding one thousand dollars or to imprisonment for a term not exceeding six months, or to both, and

(ii) for a subsequent offence, to a fine not exceeding two thousand dollars or to imprisonment for a term not exceeding one year, or to both."

Schedule I

• Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:

1. Opium
2. Codeine (methylmorphine)
3. Morphine (7,8–didehydro–4,5–epoxy–17–methylmorphinan–3,6–diol)
4. Thebaine (paramorphine)
   and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:
5. Acetorphine (acetyletorphine)
6. Acetyldihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol acetate)
7. Benzylmorphine (7,8–didehydro–4,5–epoxy–17–methyl–3–(phenylmethoxy) morphinan–6–ol)
8. Codoxime (dihydrocodeinone O–(carboxymethyl) oxime)
9. Desomorphine (dihydrodeoxymorphine)
10. Diacetylmorphine (heroin)
11. Dihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol)
12. Dihydromorphine (4,5–epoxy–17–methylmorphinan–3,6–diol)
13. Ethylmorphine (7,8–didehydro–4,5–epoxy–3–ethoxy–17–methylmorphinan–6–ol)
14. Etorphine (tetrahydro–7α–(1–hydroxy–1–methyl-butyl)–6,14–endo–ethenooripavine)
15. Hydrocodone (dihydrocodeinone)
16. Hydromorphinol (dihydro–14–hydroxymorphine)
17. Hydromorphone (dihydromorphinone)
18. Methyldesorphine (Δ6–deoxy–6–methylmorphine)
19. Methyldihydromorphine (dihydro–6–methylmorphine)
20. Metopon (dihydromethylmorphinone)
21. Morphine–N–oxide (morphine oxide)
22. Myrophine (benzylmorphine myristate)
23. Nalorphine (N–allylnormorphine)
24. Nicocodine (6–nicotinylcodeine)
25. Nicomorphine (dinicotinylmorphine)
26. Norcodeine (N–desmethylcodeine)
27. Normorphine (N–desmethylmorphine)
28. Oxycodone (dihydrohydroxycodeinone)
29. Oxymorphone (dihydrohydroxymorphinone)
30. Pholcodine (3–[2–(4–morpholinyl)ethyl]morphine)
31. Thebacon (acetyldihydrocodeinone)
    but not including:
32. Apomorphine (5,6,6a,7–tetrahydro–6–methyl–4H–dibenzo[de,g]quinoline–10,11–diol) and its salts
33. Cyprenorphine (N–(cyclopropylmethyl)–6,7,8,14–tetrahydro–7α–(1–hydroxy–1–methylethyl)–6,14–endo–ethenonororipavine) and its salts
34. Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol) and its salts
    1. Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one) and its salts
    2. Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one) and its salts
    3. Methylnaltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium) and its salts
    4. Naloxegol (4,5α-epoxy-6α-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)morphinan-3,14-diol) and its salts
35. Narcotine (6,7–dimethoxy–3–(5,6,7,8–tetra-hydro–4–methoxy–6–methyl–1,3–dioxolos [4,5–g]isoquinolin–5–yl)–1(3H)–isobenzofuranone) and its salts
36. Papaverine (1–[(3,4–dimethoxyphenyl)methyl]–6,7–dimethoxyisoquinoline) and its salts
37. Poppy seed

• Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including:

1. Coca leaves
2. Cocaine (benzoylmethylecgonine)
3. Ecgonine (3–hydroxy–2–tropane carboxylic acid)

• Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:

1. Allylprodine (3–allyl–1–methyl–4–phenyl–4–piperidinol propionate)
2. Alphameprodine (α–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
3. Alphaprodine (α–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
4. Anileridine (ethyl 1–[2–(p–aminophenyl)ethyl]–4–phenylpiperidine–4–carboxylate)
5. Betameprodine (β–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
6. Betaprodine (β–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
7. Benzethidine (ethyl 1–(2–benzyloxyethyl)–4–phenylpiperidine–4–carboxylate)
8. Diphenoxylate (ethyl 1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
9. Difenoxin (1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
10. Etoxeridine (ethyl 1–[2–(2–hydroxyethoxy) ethyl]–4–phenylpiperidine–4–carboxylate)
11. Furethidine (ethyl 1–(2–tetrahydrofurfury loxyethyl)–4–phenylpiperidine–4–carboxylate)
12. Hydroxypethidine (ethyl 4–(m–hydroxyphenyl)–1–methylpiperidine–4–carboxylate)
13. Ketobemidone (1–[4–(m–hydroxyphenyl)–1–methyl–4–piperidyl]–1–propanone)
14. Methylphenylisonipecotonitrile (4–cyano–1–methyl–4–phenylpiperidine)
15. Morpheridine (ethyl 1–(2–morpholinoethyl)–4–phenylpiperidine–4–carboxylate)
16. Norpethidine (ethyl 4–phenylpiperidine–4–carboxylate)
17. Pethidine (ethyl 1–methyl–4–phenylpiperidine–4–carboxylate)
18. Phenoperidine (ethyl 1–(3–hydroxy–3–phenylpropyl)–4–phenylpiperidine–4–carboxylate)
19. Piminodine (ethyl 1–[3–(phenylamino)propyl]–4–phenylpiperidine–4–carboxylate)
20. Properidine (isopropyl 1–methyl–4–phenylpiperidine–4–carboxylate)
21. Trimeperidine (1,2,5–trimethyl–4–phenyl–4–piperidinol propionate)
22. Pethidine Intermediate C (1–methyl–4–phenylpiperidine–4–carboxylate)
    but not including:
23. Carbamethidine (ethyl 1–(2–carbamylethyl)–4–phenylpiperidine–4–carboxylate) and its salts
24. Oxpheneridine (ethyl 1–(2–hydroxy–2–phenylethyl)–4–phenylpiperidine–4–carboxylate) and its salts

• Phenazepines, their salts, derivatives and salts of derivatives including:

1. Proheptazine (hexahydro–1,3–dimethyl–4–phenyl–1H–azepin–4–ol propionate)
   but not including:
2. Ethoheptazine (ethyl hexahydro–1–methyl–4–phenyl–azepine–4–carboxylate) and its salts
3. Metethoheptazine (ethyl hexahydro–1,3–dimethyl–4–phenylazepine–4–carboxylate) and its salts
4. Metheptazine (ethyl hexahydro–1,2–dimethyl–4–phenylazepine–4–carboxylate) and its salts

• Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including:

1. Dimethylaminodiphenylbutanonitrile (4–cyano–2–dimethylamino–4,4–diphenylbutane)
2. Dipipanone (4,4–diphenyl–6–piperidino–3–heptanone)
3. Isomethadone (6–dimethylamino–5–methyl–4,4–diphenyl–3–hexanone)
4. Methadone (6–dimethylamino–4,4–diphenyl–3–heptanone)
5. Normethadone (6–dimethylamino–4,4–diphenyl–3–hexanone)
6. Norpipanone (4,4–diphenyl–6–piperidino–3–hexanone)
7. Phenadoxone (6–morpholino–4,4–diphenyl–3–heptanone)

• Methadols, their salts, derivatives and salts of derivatives including:

1. Acetylmethadol (6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
2. Alphacetylmethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
3. Alphamethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol)
4. Betacetylmethadol (β–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
5. Betamethadol (β–6–dimethylamino–4,4–diphenyl–3–heptanol)
6. Dimepheptanol (6–dimethylamino–4,4–diphenyl–3–heptanol)
7. Noracymethadol (α–6–methylamino–4,4–diphenyl–3–heptanol acetate)

• Phenalkoxams, their salts, derivatives and salts of derivatives including:

1. Dimenoxadol (dimethylaminoethyl 1–ethoxy–1,1–diphenylacetate)
2. Dioxaphetyl butyrate (ethyl 2,2–diphenyl–4–morpholinobutyrate)
3. Dextropropoxyphene ([S–(R*,S*)]–α–[2–(dimethylamino)–1–methylethyl]–α–phenylbenzeneethanol, propanoate ester)

• Thiambutenes, their salts, derivatives and salts of derivatives including:

1. Diethylthiambutene (N,N–diethyl–1–methyl–3,3–di–2–thienylallylamine)
2. Dimethylthiambutene (N,N,1–trimethyl–3,3–di–2–thienylallylamine)
3. Ethylmethylthiambutene (N–ethyl–N,1–dimethyl–3,3–di–2–thienylallylamine)

• Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:

1. Dextromoramide (d–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
2. Diphenylmorpholinoisovaleric acid (2–methyl–3–morpholino–1,1–diphenylpropionic acid)
3. Levomoramide (l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
4. Racemoramide (d,l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl) pyrrolidine)

• Morphinans, their salts, derivatives and salts of derivatives including:

1. Buprenorphine (17–(cyclopropylmethyl)–α–(1,1–dimethylethyl)–4,5–epoxy–18,19–dihydro–3–hydroxy–6–methoxy–α–methyl–6,14–ethenomorphinan–7–methanol)
2. Drotebanol (6β,14–dihydroxy–3,4–dimethoxy–17–methylmorphinan)
3. Levomethorphan (l–3–methoxy–17–methylmorphinan)
4. Levorphanol (l–3–hydroxy–17–methylmorphinan)
5. Levophenacylmorphan (l–3–hydroxy–17–phenacylmorphinan)
6. Norlevorphanol (l–3–hydroxymorphinan)
7. Phenomorphan (3–hydroxy–17–(2–phenylethyl)morphinan)
8. Racemethorphan (d,1–3–methoxy–17–methylmorphinan)
9. Racemorphan (d,l–3–hydroxy–N–methylmorphinan)
   but not including:
10. Dextromethorphan (d–1,2,3,9,10,10a–hexahydro–6–methoxy–11–methyl–4H–10,4a–iminoethano–phenanthren) and its salts
11. Dextrorphan (d–1,2,3,9,10,10a–hexahydro–11–methyl–4H–10,4a–iminoethanophenanthren–6–ol) and its salts
12. Levallorphan (l–11–allyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol) and its salts
13. Levargorphan (l–11–propargyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol) and its salts
14. Butorphanol (17–(cyclobutylmethyl)morphinan–3,14–diol) and its salts
15. Nalbuphine (17–(cyclobutylmethyl)–4,5α–epoxymorphinan–3,6α, 14–triol) and its salts

• Benzazocines, their salts, derivatives and salts of derivatives including:

1. Phenazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–phenethyl–2,6–methano–3–benzazocin–8–ol)
2. Metazocine (1,2,3,4,5,6–hexahydro–3,6,11–trimethyl–2,6–methano–3–benzazocin–8–ol)
3. Pentazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(3–methyl–2–butenyl)–2,6–methano–3–benzazocin–8–ol)

but not including

1. Cyclazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(cyclopropylmethyl)–2,6–methano–3–benzazocin–8–ol) and its salts

• Ampromides, their salts, derivatives and salts of derivatives including:

1. Diampromide (N–[2–(methylphenethylamino)propyl] propionanilide)
2. Phenampromide (N–(1–methyl–2–piperidino) ethyl) propionanilide)
3. Propiram (N–(1–methyl–2–piperidinoethyl)–N–2–pyridylpropionamide)

• Benzimidazoles, their salts, derivatives and salts of derivatives including:

1. Clonitazene (2–(p–chlorobenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
2. Etonitazene (2–(p–ethoxybenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
3. Bezitramide (1–(3–cyano–3,3–diphenylpropyl)–4–(2–oxo–3–propionyl–1–benzimidazolinyl)–piperidine)

• Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:

1. Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)

• Piritramide (1–(3–cyano–3,3–diphenylpropyl)–4–(1–piperidino)piperidine–4–carboxylic acid amide), its salts, derivatives and salts of derivatives
• Fentanyls, their salts, derivatives, and analogues and salts of derivatives and analogues, including:

1. Acetyl–α–methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] acetanilide)
2. Alfentanil (N–[1–[2–(4–ethyl–4,5–dihydro–5–oxo–1H–tetrazol–1–yl)ethyl]–4–(methoxymethyl)–4–piperidyl]propionanilide)
3. Carfentanil (methyl 4–[(1–oxopropyl)phenylamino]–1–(2–phenethyl)–4–piperidinecarboxylate)
4. p–Fluorofentanyl (4′fluoro–N–(1–phenethyl–4–piperidyl) propionanilide)
5. Fentanyl (N–(1–phenethyl–4–piperidyl) propionanilide)
6. β–Hydroxyfentanyl (N–[1–(β–hydroxyphenethyl)–4–piperidyl] propionanilide)
7. β–Hydroxy–3–methylfentanyl (N–[1–(β–hydroxyphenethyl)–3–methyl–4–piperidyl] propionanilide)
8. α–Methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] propionanilide)
9. α–Methylthiofentanyl (N–[1–[1–methyl–2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
10. 3–Methylfentanyl (N–(3–methyl–1–phenethyl–4–piperidyl) propionanilide)
11. 3–Methylthiofentanyl (N–[3–methyl–1–[2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
    1. Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
12. Sufentanil (N–[4–(methoxymethyl)–1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)
13. Thiofentanyl (N–[1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)

• Tilidine (ethyl2–(dimethylamino)–1–phenyl–3–cyclohexene–1–carboxylate), its salts, derivatives and salts of derivatives

1. Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

• Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
• Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:

1. Amphetamine (α-methylbenzene-ethanamine)
2. N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
3. 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
4. 3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
5. 2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
6. 4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine)
7. 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine)
8. N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
9. 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
10. 5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
11. N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
12. N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
13. 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
14. 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
15. 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
16. 4-ethoxyamphetamine (4-ethoxy-α-methylbenzeneethanamine)
17. Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine)
18. N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
19. N-(2-Hydroxyethyl)-α-meth-ylbenzeneethanamine
20. N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
21. 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)

• Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives
• 4-hydroxybutanoic acid (GHB) and any of its salts
• Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers
• AH-7921 (1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine), its salts, isomers and salts of isomers
• MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including:

1. Diphenidine (DEP) (1-(1,2-diphenylethyl)piperidine)
2. Methoxphenidine (2-MeO-Diphenidine, MXP) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine)
3. Ephenidine (NEDPA, EPE) (N-ethyl-1,2-diphenylethylamine)
4. Isophenidine (NPDPA) (N-isopropyl-1,2-diphenylethylamine)
   but not including:
5. Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers

• W-18 (-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benzenesulfonamide), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

Schedule II

• Cannabis, its preparations and derivatives, including

1. Cannabis resin
2. Cannabis (marijuana)
3. Cannabidiol (2–[3–methyl–6–(1–methylethenyl)–2–cyclohexen–1–yl]–5–pentyl–1,3–benzenediol)
4. Cannabinol (3–n–amyl–6,6,9–trimethyl–6–dibenzopyran–1–ol)
5. [Repealed, SOR/2015-192, s. 1]
6. [Repealed, SOR/2015-192, s. 1]
7. Tetrahydrocannabinol (tetrahydro–6,6,9–trimethyl–3–pentyl–6H–dibenzo[b,d]pyran–1–ol)
   1. [Repealed, SOR/2015-192, s. 1]
      but not including:
8. Non–viable Cannabis seed, with the exception of its derivatives
9. Mature Cannabis stalks that do not include leaves, flowers, seeds or branches; and fiber derived from such stalks

• Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts — including those that fall within the following core chemical structure classes:

1. Any substance that has a 2-(cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3’-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including
   1. Nabilone ((±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
   2. Parahexyl (3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)
   3. 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
   4. 5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol (CP 55,940)
   5. 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497)
2. Any substance that has a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
   1. 1-pentyl-3-(1-naphthoyl)indole (JWH-018)
   2. 1-butyl-3-(1-naphthoyl)indole (JWH-073)
   3. 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)
   4. 1-hexyl-3-(1-naphthoyl)indole (JWH-019)
   5. 1-(4-pentenyl)-3-(1-naphthoyl)indole (JWH-022)
   6. 1-butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-080)
   7. 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081)
   8. 1-(2-morpholin-4-ylethyl)-3-(1-naphthoyl)indole (JWH-200)
   9. 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210)
   10. 1-pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)
   11. 1-[(N-methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220)
   12. 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201)
   13. 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201)
   14. 1-(5-fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201)
   15. ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-2)
3. Any substance that has a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
   1. 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole (JWH-307)
4. Any substance that has a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
   1. 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)
   2. 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251)
   3. 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302)
5. Any substance that has a 3-benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
   1. 1-(1-methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole (AM-2233)
6. Any substance that has a 3-methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including
   1. (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144)
   2. (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144)
   3. (1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (A-796,260)
7. Any substance that has a quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including
   1. 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22)
   2. 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22)
8. Any substance that has a 3-carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
   1. N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)
   2. N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB48)
   3. N-(1-(aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)
   4. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)
9. Any substance that has a 3-carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
   1. N-(adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135)
   2. N-(adamantan-1-yl)-1-pentylindole-3-carboxamide (APICA)

Schedule III

• [Repealed, 2012, c. 1, s. 45]
• Methylphenidate (α–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof
• Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof
• Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof
• LSD (Lysergic acid diethylamide) (N,N–diethyllysergamide) and any salt thereof
• DET (N,N–Diethyltryptamine) (3–[(2–diethylamino) ethyl]indole) and any salt thereof
• DMT (N,N–Dimethyltryptamine) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof
• N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof
• Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof
• Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof
• Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof
• Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof
• PCE (N–(1–phenylcyclohexyl)ethylamine) and any salt thereof
• TCP (1–[1–(2–Thienyl) cyclohexyl]piperidine) and any salt thereof
• PCPr (1–Phenyl–N–propylcyclohexanamine) and any salt thereof
• Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
• Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
• 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof
• Cathinone ((–)–α–aminopropiophenone) and any salt thereof
• Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof
• Methcathinone (2–Methylamino–1–phenyl–1–propanone) and any salt thereof
• Benzylcyclidine (1–[1–(Phenylmethyl)cyclohexyl]piperidine) and any salt thereof
• 4-methyl-PCP (1–[1–(4–Methylphenyl)cyclohexyl]piperidine) and any salt thereof
• [Repealed, SOR/2016-73, s. 1]
• [Repealed, 2012, c. 1, s. 46]
• [Repealed, 2012, c. 1, s. 46]
• Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof
• Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
• Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof
• Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
• Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
• Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
• BZP (Benzylpiperazine) (1-benzylpiperazine) and its salts, isomers and salts of isomers
• TFMPP (Trifluoromethylphenylpiperazine) (1-(3-trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers
• 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description :

  any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including:

1. 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)
2. 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)
3. 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)
4. 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

Schedule IV

• Barbiturates, their salts and derivatives including

1. Allobarbital (5,5–diallylbarbituric acid)
2. Alphenal (5–allyl–5–phenylbarbituric acid)
3. Amobarbital (5–ethyl–5–(3–methylbutyl)barbituric acid)
4. Aprobarbital (5–allyl–5–isopropylbarbituric acid)
5. Barbital (5,5–diethylbarbituric acid)
6. [Repealed, SOR/2017-13, s. 7]
7. Butabarbital (5–sec–butyl–5–ethylbarbituric acid)
8. Butalbital (5–allyl–5–isobutylbarbituric acid)
9. Butallylonal (5–(2–bromoallyl)–5–sec–butylbarbituric acid)
10. Butethal (5–butyl–5–ethylbarbituric acid)
11. Cyclobarbital (5–(1–cyclohexen–1–yl)–5–ethylbarbituric acid)
12. Cyclopal (5–allyl–5–(2–cyclopenten–1–yl)barbituric acid)
13. Heptabarbital (5–(1–cyclohepten–1–yl)–5–ethylbarbituric acid)
14. Hexethal (5–ethyl–5–hexylbarbituric acid)
15. Hexobarbital (5–(1–cyclohexen–1–yl)–1,5–dimethylbarbituric acid)
16. Mephobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)
17. Methabarbital (5,5–diethyl–1–methylbarbituric acid)
18. Methylphenobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)
19. Propallylonal (5–(2–bromoallyl)–5–isopropylbarbituric acid)
20. Pentobarbital (5–ethyl–5–(1–methylbutyl)barbituric acid)
21. Phenobarbital (5–ethyl–5–phenylbarbituric acid)
22. Probarbital (5–ethyl–5–isopropylbarbituric acid)
23. Phenylmethylbarbituric Acid (5–methyl–5–phenylbarbituric acid)
24. Secobarbital (5–allyl–5–(1–methylbutyl)barbituric acid)
25. Sigmodal (5–(2–bromoallyl)–5–(1–methylbutyl) barbituric acid)
26. Talbutal (5–allyl–5–sec–butylbarbituric acid)
27. Vinbarbital (5–ethyl–5–(1–methyl–1–butenyl)barbituric acid)
28. Vinylbital (5–(1–methylbutyl)–5–vinylbarbituric acid)
    but not including:
29. Barbituric Acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
30. 1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts

• Thiobarbiturates, their salts and derivatives including:

1. Thialbarbital (5–allyl–5–(2–cyclohexen–1–yl)–2–thiobarbituric acid)
2. Thiamylal (5–allyl–5–(1–methylbutyl)–2–thiobarbituric acid)
3. Thiobarbituric Acid (2–thiobarbituric acid)
4. Thiopental (5–ethyl–5–(1–methylbutyl)–2–thiobarbituric acid)

• Chlorphentermine (1–(p–chlorophenyl)–2–methyl–2–aminopropane) and any salt thereof
• Diethylpropion (2–(diethylamino)propiophenone) and any salt thereof
• Phendimetrazine (d–3,4–dimethyl–2–phenylmorpholine) and any salt thereof
• Phenmetrazine (3–methyl–2–phenylmorpholine) and any salt thereof
• Pipradol (α,α–diphenyl–2–piperidinemethanol) and any salt thereof
• Phentermine (α,α–dimethylbenzeneethanamine) and any salt thereof
• Butorphanol (l–N–cyclobutylmethyl–3,14–dihydroxymorphinan) and any salt thereof
• Nalbuphine (N–cyclobutylmethyl–4,5–epoxy–morphinan–3,6,14–triol) and any salt thereof
• Glutethimide (2–ethyl–2–phenylglutarimide)
• Clotiazepam (5–(o–chlorophenyl)–7–ethyl–1,3–dihydro–1–methyl–2H–thieno[2,3–e]–1,4–diazepin–2–one) and any salt thereof
• Ethchlorvynol (ethyl–2–chlorovinyl ethynyl carbinol)
• Ethinamate (1–ethynylcyclohexanol carbamate)
• Mazindol (5–(p–chlorophenyl)–2,5–dihydro–3H–imidazo[2,1–a]isoindol–5–ol)
• Meprobamate (2–methyl–2–propyl–1,3–propanediol dicarbamate)
• Methyprylon (3,3–diethyl–5–methyl–2,4–piperidinedione)
• Benzodiazepines, their salts and derivatives, including:

1. Alprazolam (8–chloro–1–methyl–6–phenyl–4H–s–triazolo[4,3–a][1,4] benzodiazepine)
2. Bromazepam (7–bromo–1,3–dihydro–5–(2–pyridyl)–2H–1, 4–benzodiazepin–2–one)
   1. Brotizolam (2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
3. Camazepam (7–chloro–1,3–dihydro–3–(N,N– dimethylcarbamoyl)–1–methyl–5–phenyl–2H–1, 4–benzodiazepin–2–one)
4. Chlordiazepoxide (7–chloro–2–(methylamino)–5–phenyl–3H–1,4–benzodiazepine–4–oxide)
5. Clobazam (7–chloro–1–methyl–5–phenyl–1H–1,5–benzodiazepine–2,4(3H,5H)–dione)
6. Clonazepam (5–(o–chlorophenyl)–1,3–dihydro–7–nitro–2H–1,4–benzodiazepin–2–one)
7. Clorazepate (7–chloro–2,3–dihydro–2,2–dihydroxy–5–phenyl–1H–1,4–benzodiazepine–3–carboxylic acid)
8. Cloxazolam (10–chloro–11b–(o–chlorophenyl)–2,3, 7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin 6–(5H)–one)
9. Delorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)
10. Diazepam (7–chloro–1,3–dihydro–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)
11. Estazolam (8–chloro–6–phenyl–4H–s–triazolo [4,3–a][1,4]benzodiazepine)
12. Ethyl Loflazepate (ethyl 7–chloro–5–(o–fluorophenyl)–2,3–dihydro–2–oxo–1H–1,4–benzodiazepine–3–carboxylate)
13. Fludiazepam (7–chloro–5–(o–fluorophenyl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)
14. [Repealed, SOR/98-173, s. 2]
15. Flurazepam (7–chloro–1–[2–(diethylamino) ethyl]–5–(o–fluorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)
16. Halazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2,2,2–trifluoroethyl)–2H–1,4–benzodiazepin–2–one)
17. Haloxazolam (10–bromo–11b–(o–fluorophenyl)–2,3,7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin–6(5H)–one)
18. Ketazolam (11–chloro–8,12b–dihydro–2,8–dimethyl–12b–phenyl–4H–[1,3]–oxazino–[3,2–d][1,4] benzodiazepine–4,7(6H)–dione)
19. Loprazolam (6–(o–chlorophenyl)–2,4–dihydro–2–[(4–methyl–1–piperazinyl)methylene]–8–nitro–1H–imidazo[1,2–a][1,4]benzodiazepin–1–one)
20. Lorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–2H–1,4–benzodiazepin–2–one)
21. Lormetazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–1–methyl–2H–1,4–benzodiazepin–2–one)
22. Medazepam (7–chloro–2,3–dihydro–1–methyl–5–phenyl–1H–1,4–benzodiazepine)
    1. Midazolam (8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)
23. Nimetazepam (1,3–dihydro–1–methyl–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)
24. Nitrazepam (1,3–dihydro–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)
25. Nordazepam (7–chloro–1,3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)
26. Oxazepam (7–chloro–1,3–dihydro–3–hydroxy–5–phenyl–2H–1,4–benzodiazepin–2–one)
27. Oxazolam (10–chloro–2,3,7,11b–tetrahydro–2–methyl–11b–phenyloxazolo[3,2–d] [1,4]benzodiazepin–6(5H)–one)
28. Pinazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2–propynyl)–2H–1,4–benzodiazepin–2–one)
29. Prazepam (7–chloro–1–(cyclopropylmethyl)–1, 3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)
    1. Quazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione)
30. Temazepam (7–chloro–1,3–dihydro–3–hydroxy–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)
31. Tetrazepam (7–chloro–5–(cyclohexen–1–yl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)
32. Triazolam (8–chloro–6–(o–chlorophenyl)–1–methyl–4H–s–triazolo[4,3–a][1,4]benzodiazepine)
    but not including:
33. Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and any salt thereof
34. Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
35. Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts
36. Clozapine N-oxide (8-chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and its salts

• Catha edulis Forsk., its preparations, derivatives, alkaloids and salts, including:

1. Cathine (d–threo–2–amino–1–hydroxy–1–phenylpropane)

• Fencamfamin (d,l–N–ethyl–3–phenylbicyclo[2,2,1] heptan–2–amine) and any salt thereof
• Fenproporex (d,l–3–[(α–methylphenethyl)amino]propionitrile) and any salt thereof
• Mefenorex (d,l–N–(3–chloropropyl)–α–methylbenzeneethanamine) and any salt thereof
• Anabolic steroids and their derivatives including:

1. Androisoxazole (17ß–hydroxy–17α–methylandrostano [3,2–c]isoxazole)
2. Androstanolone (17ß–hydroxy–5α–androstan–3–one)
3. Androstenediol (androst–5–ene–3ß,17ß–diol)
4. Bolandiol (estr–4–ene–3ß,17ß–diol)
5. Bolasterone (17ß–hydroxy–7α,17–dimethylandrost–4–en–3–one)
6. Bolazine (17ß–hydroxy–2α–methyl–5α–androstan–3–one azine)
7. Boldenone (17ß–hydroxyandrosta–1,4–dien–3–one)
8. Bolenol (19–nor–17α–pregn–5–en–17–ol)
9. Calusterone (17ß–hydroxy–7ß,17–dimethylandrost–4–en–3–one)
10. Clostebol (4–chloro–17ß–hydroxyandrost–4–en–3–one)
11. Drostanolone (17ß–hydroxy–2α–methyl–5α–androstan–3–one)
12. Enestebol (4, 17ß–dihydroxy–17–methylandrosta–1,4–dien–3–one)
13. Epitiostanol (2α, 3α–epithio–5α–androstan–17ß–ol)
14. Ethylestrenol (19–nor–17α–pregn–4–en–17–ol)
15. 4–Hydroxy–19–nor testosterone
16. Fluoxymesterone (9–fluoro–11ß,17ß–dihydroxy–17–methylandrost–4–en–3–one)
17. Formebolone (11α, 17ß–dihydroxy–17–methyl–3–oxoandrosta–1,4 di–en–2–carboxaldehyde)
18. Furazabol (17–methyl–5α–androstano[2,3–c] furazan–17ß–ol)
19. Mebolazine (17ß–hydroxy–2α,17–dimethyl–5α–androstan–3–one azine)
20. Mesabolone (17ß–[(1–methoxycyclohexyl)oxy]–5α–androst–1–en–3–one)
21. Mesterolone (17ß–hydroxy–1α–methyl–5α–androstan–3–one)
22. Metandienone (17ß–hydroxy–17–methylandrosta–1,4–dien–3–one)
23. Metenolone (17ß–hydroxy–1–methyl–5α–androst–1–en–3–one)
24. Methandriol (17α–methylandrost–5–ene–3ß,17ß–diol)
25. Methyltestosterone (17ß–hydroxy–17–methylandrost–4–en–3–one)
26. Metribolone (17ß–hydroxy–17–methylestra–4, 9,11–trien–3–one)
27. Mibolerone (17ß–hydroxy–7α,17–dimethylestr–4–en–3–one)
28. Nandrolone (17ß–hydroxyestr–4–en–3–one)
29. Norboletone (13–ethyl–17ß–hydroxy–18, 19–dinorpregn–4–en–3–one)
30. Norclostebol (4–chloro–17ß–hydroxyestr–4–en–3–one)
31. Norethandrolone (17α–ethyl–17ß–hydroxyestr–4–en–3–one)
32. Oxabolone (4,17ß–dihydroxyestr–4–en–3–one)
33. Oxandrolone (17ß–hydroxy–17–methyl–2–oxa–5α–androstan–3–one)
34. Oxymesterone (4,17ß–dihydroxy–17–methylandrost–4–en–3–one)
35. Oxymetholone (17ß–hydroxy–2–(hydroxymethylene)–17–methyl–5α–androstan–3–one)
36. Prasterone (3ß–hydroxyandrost–5–en–17–one)
37. Quinbolone (17ß–(1–cyclopenten–1–yloxy) androsta–1,4–dien–3–one)
38. Stanozolol (17ß–hydroxy–17–methyl–5α–androstano [3,2–c]pyrazole)
39. Stenbolone (17ß–hydroxy–2–methyl–5α–androst–1–en–3–one)
40. Testosterone (17ß–hydroxyandrost–4–en–3–one)
41. Tibolone ((7α,17α)-17–hydroxy–7–methyl–19–norpregn–5(10) en–20–yn–3–one)
42. Tiomesterone (1α,7α–bis(acetylthio)–17ß –hydroxy–17–methylandrost–4–en–3–one)
43. Trenbolone (17ß–hydroxyestra–4,9,11–trien–3–one)

• Zeranol (3,4,5,6,7,8,9,10,11,12–decahydro–7,14,16– trihydroxy–3–methyl–1H–2–benzoxacyclotetradecin–1–one)
• Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof

1. Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof

• Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
• Salvia divinorum (S. divinorum), its preparations and derivatives, including:

1. Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)

Schedule V

• [Repealed, SOR/2002-361, s. 1]
• Propylhexedrine (1–cyclohexyl–2–methylaminopropane) and any salt thereof
• [Repealed, SOR/2003-32, s. 7]

Schedule VI (Precursors)

PART 1

Class A Precursors

• Acetic anhydride
• N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts
• Anthranilic acid (2-aminobenzoic acid) and its salts
• Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts
• Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts
• Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts
• Isosafrole (5-(1-propenyl)-1,3-benzodioxole)
• Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts
• 3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone)
• Norephedrine (Phenylpropanolamine) and its salts
• 1-Phenyl-2-propanone
• Phenylacetic acid and its salts
• Piperidine and its salts
• Piperonal (1,3-benzodioxole-5-carboxaldehyde)
• Potassium permanganate
• Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts
• Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole
• Gamma-butyrolactone (dihydro-2(3H)-furanone)
• 1,4-butanediol
• Red Phosphorus
• White Phosphorus
• Hypophosphorous acid, its salts and derivatives
• Hydriodic acid
• Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers

PART 2

Class B Precursors

• Acetone
• Diethyl ether
• Hydrochloric acid
• Methyl ethyl ketone
• Sulphuric acid
• Toluene

PART 3

Preparations and Mixtures

• Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23 [Red Phosphorus; White Phosphorus; Hypophosphorous acid, its salts and derivatives; Hydriodic acid], or in Part 2.

Schedule VII

Substance	Amount
Cannabis resin	3 kg
Cannabis (marijuana)	2 kg

Schedule VIII

Substance	Amount
Cannabis resin	1 g
Cannabis (marijuana)	30 g

Laws

Possession

If treated as an indictable offence, the penalty is:

Schedule I: Maximum 7 years imprisonment
Schedule II: (exceeding amounts set in Schedule VIII): Maximum 5 years imprisonment
Schedule III: (Requires a prescription or license to legally possess.) Maximum 3 years imprisonment
Schedule IV: It is not an indictable offence to possess a Schedule IV substance for personal use.

If treated as a summary conviction offence, the penalty is:

Schedule I, II, or III: Maximum $1000 fine for the first offence and/or a maximum 6-month term of imprisonment, increasing to a maximum fine of $2000 for each subsequent offense and/or a maximum of 1 year in prison.
Schedule IV: It is not a summary offence to possess a Schedule IV substance for personal use.

Note: For amounts not exceeding those set in Schedule VIII, maximum fine of $1000 and/or maximum 6 months imprisonment is the only punishment.

It should also be noted that Section (4), Subsection (2) of the CDSA reads that any person who obtains or who makes any attempt to obtain a Schedule I through IV substance from a physician without fully disclosing the details of any previous instances of obtaining a Schedule I through IV substance in the preceding thirty (30) days, a practice often referred to as "doctor shopping", is guilty of a summary or indictable offense, as per Section (4), Subsection (7)(a) and (b).

Trafficking/Possession for the Purpose of

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II (exceeding amounts set in Schedule VII): Maximum life imprisonment

• Mandatory minimum 1-year jail sentence for trafficking a Schedule I drug under 1 kg, 2 years if amount exceeds 2 kg

Schedule II (not exceeding amounts set in Schedule VII): Maximum 5 years imprisonment
Schedule III: Maximum 10 years imprisonment
Schedule IV: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III: Maximum 18 months imprisonment
Schedule IV: Maximum 1 year imprisonment

Exportation/Possession for the Purpose of

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II: Maximum life imprisonment
Schedule III or Schedule IV: Maximum 10 years imprisonment
Schedule V or Schedule VI: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III or Schedule IV: Maximum 18 months imprisonment
Schedule V or Schedule VI: Maximum 1 year imprisonment

Production

If tried as an indictable offence, the defendant is liable to:

Schedule I or Schedule II (excluding cannabis): Maximum life imprisonment
Cannabis: Maximum 7 years imprisonment
Schedule III: Maximum 10 years imprisonment
Schedule IV: Maximum 3 years imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

Schedule III: Maximum 18 months imprisonment
Schedule IV: Maximum 1 year imprisonment

Amendments to the act

In November 2007, the Justice Minister Rob Nicholson introduced Bill C-26, which proposed a number of mandatory minimum penalties imposed on those who commit drug offences. On February 27, 2009 bill C-15, a re-introduction of C-26 received first reading in the 2nd Session of the 40th Parliament of Canada. On June 9, 2009, the House of Commons passed Bill C-15, and it is now awaiting study and approval by the Senate. On December 14, 2009, the Senate passed Bill C-15, with some amendments, for approval by the House of Commons. When the Canadian Parliament dissolved in a prorogation on January 31, 2010, Bill C15, along with all unpassed legislation then tabled before the Commons, fell. Early in 2012, the next parliament passed Bill C-10, receiving Royal Assent in March. The final legislation sees changes made to four areas of the CDSA, outlining mandatory minimum sentences for offences relating to the trafficking and production of various controlled substances. Mandatory minimum sentencing does not apply to simple possession and trafficking in smaller amounts.

See also

• Controlled Substances Act (US)
• Misuse of Drugs Act 1971 (UK)

References

• http://laws-lois.justice.gc.ca/eng/acts/C-38.8/
• http://www.parl.gc.ca/LegisInfo/BillDetails.aspx?Language=E&Mode=1&billId=5120829&View=0

External links

• Controlled Drugs and Substances Act.
• Controlled Drugs and Substances Act The schedules of the Act, with the chemical name and structure of each substance. Correlates the drugs and substances of the Act with those named in the UK Misuse of Drugs Act 1971, the United States Controlled Substances Act and three United Nations treaties, the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances
• Amendments to the Controlled Drugs and Substances Act [Bill C-10, Part 2, Clauses 32-33, 39-48 and 50-51 (Former Bill S-10)]